These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2136389)

  • 21. Frontal lobe hypometabolism and impaired insight in Alzheimer disease.
    Harwood DG; Sultzer DL; Feil D; Monserratt L; Freedman E; Mandelkern MA
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):934-41. PubMed ID: 16286436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type.
    Grady CL; Haxby JV; Horwitz B; Berg G; Rapoport SI
    Neuropsychologia; 1987; 25(5):807-16. PubMed ID: 3501553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia.
    van Gorp WG; Mandelkern MA; Gee M; Hinkin CH; Stern CE; Paz DK; Dixon W; Evans G; Flynn F; Frederick CJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):280-7. PubMed ID: 1498579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography in familial Alzheimer disease.
    Kennedy AM; Rossor MN; Frackowiak RS
    Alzheimer Dis Assoc Disord; 1995; 9(1):17-20. PubMed ID: 7605617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
    Buchsbaum MS; Shihabuddin L; Hazlett EA; Schröder J; Haznedar MM; Powchik P; Spiegel-Cohen J; Wei T; Singer MB; Davis KL
    Schizophr Res; 2002 May; 55(1-2):25-40. PubMed ID: 11955961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomographic studies during serial word-reading by normal and dyslexic adults.
    Gross-Glenn K; Duara R; Barker WW; Loewenstein D; Chang JY; Yoshii F; Apicella AM; Pascal S; Boothe T; Sevush S
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):531-44. PubMed ID: 1918284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
    Martin PR; Rio D; Adinoff B; Johnson JL; Bisserbe JC; Rawlings RR; Rohrbaugh JW; Stapleton JM; Eckardt MJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):159-67. PubMed ID: 1627977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age, sex and laterality effects on cerebral glucose metabolism in healthy adults.
    Willis MW; Ketter TA; Kimbrell TA; George MS; Herscovitch P; Danielson AL; Benson BE; Post RM
    Psychiatry Res; 2002 Feb; 114(1):23-37. PubMed ID: 11864807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral cortical hypometabolic area in 18F-FDG positron emission tomography inversely relates to the duration of deafness in prelingually deaf patients.
    Kim CS; Oh SH; Kim JW; Chang SO; Song BH; Lee JS; Lee DS; Kim SK
    Adv Otorhinolaryngol; 2000; 57():51-4. PubMed ID: 11892214
    [No Abstract]   [Full Text] [Related]  

  • 32. Thalamocortical diaschisis: positron emission tomography in humans.
    Baron JC; Levasseur M; Mazoyer B; Legault-Demare F; Mauguière F; Pappata S; Jedynak P; Derome P; Cambier J; Tran-Dinh S
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):935-42. PubMed ID: 1431957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images.
    Kitagaki H; Mori E; Yamaji S; Ishii K; Hirono N; Kobashi S; Hata Y
    Radiology; 1998 Aug; 208(2):431-9. PubMed ID: 9680572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of PET in dementia disorders.
    Nordberg A
    Acta Neurol Scand Suppl; 1996; 168():71-6. PubMed ID: 8997424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia.
    Haxby JV; Grady CL; Duara R; Schlageter N; Berg G; Rapoport SI
    Arch Neurol; 1986 Sep; 43(9):882-5. PubMed ID: 3488728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S; Goldman S; Giladi N; Dhawan V; Takikawa S; Hildebrand J; Fahn S; Eidelberg D
    Adv Neurol; 1993; 60():501-5. PubMed ID: 8420178
    [No Abstract]   [Full Text] [Related]  

  • 37. Brain hypometabolism of glucose in anorexia nervosa: a PET scan study.
    Delvenne V; Lotstra F; Goldman S; Biver F; De Maertelaer V; Appelboom-Fondu J; Schoutens A; Bidaut LM; Luxen A; Mendelwicz J
    Biol Psychiatry; 1995 Feb; 37(3):161-9. PubMed ID: 7727624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypometabolism in olfactory cortical projection areas of male patients with schizophrenia: an initial positron emission tomography study.
    Bertollo DN; Cowen MA; Levy AV
    Psychiatry Res; 1996 Mar; 60(2-3):113-6. PubMed ID: 8723301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping histology to metabolism: coregistration of stained whole-brain sections to premortem PET in Alzheimer's disease.
    Mega MS; Chen SS; Thompson PM; Woods RP; Karaca TJ; Tiwari A; Vinters HV; Small GW; Toga AW
    Neuroimage; 1997 Feb; 5(2):147-53. PubMed ID: 9345544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.
    Blin J; Vidailhet MJ; Pillon B; Dubois B; Feve JR; Agid Y
    Mov Disord; 1992 Oct; 7(4):348-54. PubMed ID: 1484530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.